With a market cap of $9.5 billion, Bio-Rad Laboratories, Inc. (BIO) operates in the healthcare and life sciences industry. The Hercules, California-based company develops and manufactures a wide range of clinical diagnostics and life science research products, serving markets such as biopharmaceuticals, genomics, proteomics, and food safety. Companies valued at less than $10 billion are generally considered “mid-cap” stocks and Bio-Rad Laboratories fits this criterion perfectly. Bio-Rad Laboratories is renowned for its pioneering Digital Droplet technology, which offers unmatched precision and…